Kiniksa Pharmaceuticals(KNSA)
$95.02+-3.74 (+1.24%)
KNSA
Kiniksa Pharmaceuticals Revenue
$95.02
At close:+-3.74 (+1.24%)
Want to see KNSA full AI Analyst Report?
Kiniksa Pharmaceuticals (KNSA) Revenue
621 Followers
Kiniksa Pharmaceuticals Revenue
Kiniksa Pharmaceuticals had a revenue of 285.97M in the quarter ending Sep 30, 2026, with 17.39%. This bring the company's revenue in the last twelve months to 945.96M, Increased 12.50%. In the fiscal year ending Dec 31, 2025, Kiniksa Pharmaceuticals had annual revenue of 677.56M with 60.09% growth.
- Revenue (ttm)
- 945.96M
- Revenue Growth
- 58.19%
- P/S Ratio
- 11.02
- Revenue/Employee
- $1,851,268
- Employees
- 366
- Market Cap
- $7.47B
Revenue Chart
Kiniksa Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.56M | 254.32M | 60.09% |
| Dec 31, 2024 | 423.24M | 152.98M | 56.60% |
| Dec 31, 2023 | 270.26M | 50.08M | 22.74% |
| Dec 31, 2022 | 220.18M | 181.64M | 471.24% |
| Dec 31, 2021 | 38.54M | 38.54M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.